Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma
Clinical trial NCT00377052 · COMPLETED
Trial details
- NCT number
- NCT00377052
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-16
- Primary completion
- 2009-04-21
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.